DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
143 hedge funds and large institutions have $351M invested in DermTech, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 51 increasing their positions, 37 reducing their positions, and 50 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 37
12% less funds holding
Funds holding: 162 → 143 (-19)
36% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 50
46% less capital invested
Capital invested by funds: $647M → $351M (-$296M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
57% less call options, than puts
Call options by funds: $2.2M | Put options by funds: $5.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$24M |
| 2 |
State Street
Boston,
Massachusetts
|
+$19.7M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$14.7M |
| 4 |
AAMU
AEGON Asset Management (UK)
Edinburgh,
United Kingdom
|
+$12.2M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$11.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$34.4M |
| 2 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$12.9M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$9.63M |
| 4 |
RA
Royce & Associates
New York
|
-$8.42M |
| 5 |
FAM
Fred Alger Management
New York
|
-$7.19M |
DMTK Hedge Fund Activity: Q4 2021 in Review
143 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q4 2021, worth a combined $351M — down 46% from $647M a quarter earlier.
Sellers outnumbered buyers: 50 funds closed out of DMTK and 32 opened new positions — a net loss of 18 holders — while 37 trimmed existing stakes and 51 added.
The largest buyer was UBS O'Connor, adding an estimated $24M. The largest seller was Federated Hermes, exiting entirely with an estimated $34.4M sold.
- 143 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q4 2021, down from 162 in Q3 2021.
- Funds reported $351M of DermTech, Inc. Common Stock stock for Q4 2021, down 46% quarter-over-quarter.
- 32 funds opened new DermTech, Inc. Common Stock positions in Q4 2021 and 50 closed out, a net change of -18 holders.
- The largest DermTech, Inc. Common Stock buyer in Q4 2021 was UBS O'Connor, an estimated $24M added.
- The largest DermTech, Inc. Common Stock seller in Q4 2021 was Federated Hermes, an estimated $34.4M sold.
Based on aggregated 13F filings for Q4 2021.